RE:LatestI am doubtful about Well being an attractive investment. To start, well is becoming highly diversified (EMR, clinincs, telehealth, AI, investment in Insig, etc...) and furthermore I do not believe Well management would want to work for someone else...
On the other hand, I see DOC as an attractive investment target...mainly focused on telehealth and pharmacy kiosks. Stock is still cheap and this can provide a ready-to-use solution to many potential buyers.
In any acquisition scenario, this will be done at a premium on current stock price...so any shareholders of Well or Doc are in a very good prositions. glta